Shots: The P-III A4091059 study involves assessing of tanezumab (5mg,10mg) vs PBO vs tramadol (prolonged release) in 1,832 in the ratio 2:2:2:3 with moderate-to-severe chronic low back pain (CLBP) in […]readmore
Tags : Tags: Pfizer